https://thebostonexaminer.com/article/907332127-influential-women-profiles-melissa-gilbo-heart-centered-leader-entrepreneur-and-founder-of-women-s-business-league The Boston Examiner en PressRelease 2026-04-22T13:38:12+00:00 Influential Women Profiles: Melissa Gilbo, Heart-Centered Leader, Entrepreneur, and Founder of Women’s Business League https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24838392-melissa-gilbo-398x392.png https://thebostonexaminer.com/article/907330235-influential-women-spotlights-jillayne-torrey-flanders-advancing-equity-leadership-and-whole-child-education The Boston Examiner en PressRelease 2026-04-22T13:33:19+00:00 Influential Women Spotlights Jillayne Torrey Flanders: Advancing Equity, Leadership, and Whole-Child Education https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24838381-jillayne-torrey-flanders-394x394.png https://thebostonexaminer.com/article/907312313-head-of-the-charles-regatta-names-new-chair-two-new-members-to-regatta-board The Boston Examiner en PressRelease 2026-04-22T13:00:00+00:00 HEAD OF THE CHARLES REGATTA NAMES NEW CHAIR, TWO NEW MEMBERS TO REGATTA BOARD https://thebostonexaminer.com/article/907172877-new-best-practice-guide-for-ensuring-accessible-math-in-pdf-files The Boston Examiner en PressRelease 2026-04-22T12:30:00+00:00 New Best Practice Guide for Ensuring Accessible Math in PDF files https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24792042-accessible-stem-content-toolcha-2106x418.png https://thebostonexaminer.com/article/907141402-coastal-heritage-bank-announces-senior-leadership-promotions The Boston Examiner en PressRelease 2026-04-22T12:00:00+00:00 Coastal Heritage Bank Announces Senior Leadership Promotions https://thebostonexaminer.com/article/907143208-coastal-heritage-bank-announces-retirement-of-maria-vafiades The Boston Examiner en PressRelease 2026-04-22T12:00:00+00:00 Coastal Heritage Bank Announces Retirement of Maria Vafiades https://thebostonexaminer.com/article/907242311-env-zero-launches-cloudquery-insights-to-eliminate-cloudquery-insightsmanual-cloud-investigation-for-platform-teams The Boston Examiner en PressRelease 2026-04-22T12:00:00+00:00 env zero Launches CloudQuery Insights to Eliminate CloudQuery InsightsManual Cloud Investigation for Platform Teams https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24813556-envzero2-1000x123.png https://thebostonexaminer.com/article/907039799-ten-ad-platforms-one-login-adplus-opens-its-public-beta The Boston Examiner en PressRelease 2026-04-22T11:00:00+00:00 Ten ad platforms, one login: AdPlus opens its public beta https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24836907-adplus-logo-1640x440.png https://thebostonexaminer.com/article/906238408-a-new-chapter-begins-for-billerica-chiropractic-office The Boston Examiner en PressRelease 2026-04-22T09:34:40+00:00 A New Chapter Begins for Billerica Chiropractic Office https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24834909-billerica-chiropractic-logo-ima-245x58.png https://thebostonexaminer.com/article/907265568-mercer-island-chiropractic-launches-new-golf-rest-program-to-improve-performance-and-enhance-golf-swings The Boston Examiner en PressRelease 2026-04-22T05:56:29+00:00 Mercer Island Chiropractic Launches New Golf Rest Program to Improve Performance and Enhance Golf Swings https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24837990-mercer-island-chiropractic-260x64.jpeg https://thebostonexaminer.com/article/907255577-us-teen-leadership-summit-held-in-new-york-clash-of-teen-innovation-and-leadership-in-the-ai-era The Boston Examiner en PressRelease 2026-04-22T05:42:31+00:00 US Teen Leadership Summit Held in New York: Clash of Teen Innovation and Leadership in the AI Era https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24837961-crew-4096x2562.jpeg https://thebostonexaminer.com/article/907335145-access-continues-multinational-expansion-of-its-information-management-business-with-strategic-acquisitions-across-the-americas The Boston Examiner en PressRelease 2026-04-22T13:00:00+00:00 Access Continues Multinational Expansion of Its Information Management Business with Strategic Acquisitions Across the Americas https://ml.globenewswire.com/media/4acdf1c6-440f-4316-bdea-7f0e517f8059/small/access-logo-rgb-full-color2020-jpg.jpg https://thebostonexaminer.com/article/907335793-reversinglabs-expert-personnel-join-global-cyber-defense-teams-at-nato-s-ccdcoe-locked-shields The Boston Examiner en PressRelease 2026-04-22T13:00:00+00:00 ReversingLabs Expert Personnel Join Global Cyber Defense Teams at NATO’s CCDCOE Locked Shields https://ml.globenewswire.com/media/fe1c3347-a02e-418d-b1d7-d67712d3a4dc/small/logo-1-line-rb-png.png https://thebostonexaminer.com/article/907336133-eleos-expands-ai-agents-across-the-full-care-journey The Boston Examiner en PressRelease 2026-04-22T13:00:00+00:00 Eleos Expands AI Agents Across the Full Care Journey https://ml.globenewswire.com/media/231b5a81-1485-459d-929d-c0fe63ecdf90/small/eleos-logo-cmyk-og-png.png https://thebostonexaminer.com/article/907336201-ip-fabric-mcp-server-eliminates-barriers-to-enterprise-aiops-adoption The Boston Examiner en PressRelease 2026-04-22T13:00:00+00:00 IP Fabric MCP Server Eliminates Barriers to Enterprise AIOps Adoption https://ml.globenewswire.com/media/45032796-afd7-44df-83bf-9f15609cc7cd/medium/ip-fabric-s-enterprise-mcp-server.png https://thebostonexaminer.com/article/907336379-paragonix-announces-technology-upgrade-to-industry-leading-sherpapak-cardiac-transport-system The Boston Examiner en PressRelease 2026-04-22T13:00:00+00:00 Paragonix Announces Technology Upgrade to Industry Leading SherpaPak® Cardiac Transport System https://ml.globenewswire.com/media/5b56fec1-dc1d-480e-8a0b-aa723d7e7cf9/small/paragonix-getinge-bluecenter-png.png https://thebostonexaminer.com/article/907337093-knowbe4-selects-flywire-as-global-payments-partner-to-transform-international-invoice-to-cash-operations The Boston Examiner en PressRelease 2026-04-22T13:00:00+00:00 KnowBe4 Selects Flywire as Global Payments Partner to Transform International Invoice-to-Cash Operations https://ml.globenewswire.com/media/9b1123f3-5f90-4036-ab7b-c4c3d1f5491b/small/flywire-logo-jpg.jpg https://thebostonexaminer.com/article/907335149-wave-life-sciences-first-quarter-2026-financial-results-scheduled-for-april-28-2026 The Boston Examiner en PressRelease 2026-04-22T12:30:00+00:00 Wave Life Sciences First Quarter 2026 Financial Results Scheduled for April 28, 2026 https://ml.globenewswire.com/media/b2c5e218-8ae8-4dc2-b6f2-cf55b6b3b6e0/small/wave-life-sciences-logo-jpg.jpg https://thebostonexaminer.com/article/907335565-thrive-launches-abacode-compliance-services-to-help-organizations-build-and-maintain-continuous-compliance The Boston Examiner en PressRelease 2026-04-22T12:30:00+00:00 Thrive Launches Abacode Compliance Services to Help Organizations Build and Maintain Continuous Compliance https://ml.globenewswire.com/media/fcaf797c-9107-49f6-bd64-eeb1f1ad37b1/small/thrive-logo-jpg.jpg https://thebostonexaminer.com/article/907336154-microbot-medical-welcomes-updated-occupational-protection-guidelines-from-leading-medical-societies-strengthening-commercial-position-of-liberty The Boston Examiner en PressRelease 2026-04-22T12:30:00+00:00 Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY® https://ml.globenewswire.com/media/346df7fb-c134-40c2-970a-39bcbaf974cd/small/mbot-logo-rgb-jpg.jpg https://thebostonexaminer.com/article/907322224-acronis-launches-genai-protection-enabling-msps-to-secure-and-govern-ai-usage The Boston Examiner en PressRelease 2026-04-22T12:00:00+00:00 Acronis Launches GenAI Protection, Enabling MSPs to Secure and Govern AI Usage https://ml.globenewswire.com/media/c95d96ce-8d59-4996-b1ad-c85aaa88c483/medium/acronis-genai-protection.png https://thebostonexaminer.com/article/907323314-corbus-pharmaceuticals-announces-abstracts-accepted-for-presentation-at-asco-2026-featuring-updated-clinical-data-for-crb-701 The Boston Examiner en PressRelease 2026-04-22T12:00:00+00:00 Corbus Pharmaceuticals Announces Abstracts Accepted for Presentation at ASCO 2026 Featuring Updated Clinical Data for CRB-701 https://ml.globenewswire.com/media/459d6fb1-b336-4d47-8aa1-f9198bda891d/small/corbus-logo-jpg.jpg https://thebostonexaminer.com/article/907326065-earned-names-veteran-manager-greg-dicenzo-as-ambassador The Boston Examiner en PressRelease 2026-04-22T12:00:00+00:00 EARNED Names Veteran Manager Greg DiCenzo as Ambassador https://ml.globenewswire.com/media/e2e773a0-13f1-4699-bdf7-7dea35620936/medium/greg-dicenzo-professional-baseball-manager.jpg https://thebostonexaminer.com/article/907323039-zevra-therapeutics-announces-details-for-q1-2026-financial-results-call The Boston Examiner en PressRelease 2026-04-22T11:30:00+00:00 Zevra Therapeutics Announces Details for Q1 2026 Financial Results Call https://ml.globenewswire.com/media/cf39ab90-8c07-407d-a7ea-b7c9d48d44c4/small/zevra-inline-fullcolor-rgb-12in-300ppi-1-png.png https://thebostonexaminer.com/article/907323651-repligen-to-report-first-quarter-2026-financial-results The Boston Examiner en PressRelease 2026-04-22T11:30:00+00:00 Repligen to Report First Quarter 2026 Financial Results https://ml.globenewswire.com/media/967d43f6-7ffd-4ee0-8804-e3c12952402f/small/repligen-logo-horizontal-withtagline-1-jpg.jpg https://thebostonexaminer.com/article/907324170-cervomed-announces-new-data-at-the-2026-aan-annual-meeting-that-demonstrated-neflamapimod-increased-basal-forebrain-volume-and-functional-connectivity The Boston Examiner en PressRelease 2026-04-22T11:30:00+00:00 CervoMed Announces New Data at the 2026 AAN Annual Meeting that Demonstrated Neflamapimod Increased Basal Forebrain Volume and Functional Connectivity in Dementia with Lewy Bodies https://ml.globenewswire.com/media/332fd58e-5e2b-4c96-8eaf-719ac2e34f52/small/cervomed-logo-png.png https://thebostonexaminer.com/article/907322344-jade-biosciences-appoints-edward-r-conner-m-d-as-chief-medical-officer The Boston Examiner en PressRelease 2026-04-22T11:00:00+00:00 Jade Biosciences Appoints Edward R. Conner, M.D., as Chief Medical Officer https://ml.globenewswire.com/media/74b5b00e-9a9e-4581-801b-a6e2ddab3aab/small/jade-logo-full-color-rgb-jpg.jpg https://thebostonexaminer.com/article/907322354-sironax-announces-abstract-on-sarm1-inhibitor-sir2501-selected-for-presentation-at-2026-asco-annual-meeting The Boston Examiner en PressRelease 2026-04-22T11:00:00+00:00 Sironax Announces Abstract on SARM1 Inhibitor SIR2501 Selected for Presentation at 2026 ASCO Annual Meeting https://ml.globenewswire.com/media/324eaac0-0f76-4b80-8917-0c56a174ae30/small/sironax-logo-768x768-png.png https://thebostonexaminer.com/article/907322778-sarm1-sir2501-2026-asco The Boston Examiner en PressRelease 2026-04-22T11:00:00+00:00 维泰瑞隆宣布其SARM1抑制剂SIR2501相关摘要获选2026年美国临床肿瘤学会（ASCO）年会海报展示 https://ml.globenewswire.com/media/324eaac0-0f76-4b80-8917-0c56a174ae30/small/sironax-logo-768x768-png.png https://thebostonexaminer.com/article/907322787-sarm1-sir2501-2026-asco The Boston Examiner en PressRelease 2026-04-22T11:00:00+00:00 維泰瑞隆宣佈其SARM1抑制劑SIR2501相關摘要獲選2026年美國臨床腫瘤學會（ASCO）年會海報展示 https://ml.globenewswire.com/media/324eaac0-0f76-4b80-8917-0c56a174ae30/small/sironax-logo-768x768-png.png https://thebostonexaminer.com/article/907323138-ocular-therapeutix-to-host-investor-day-on-june-17-2026 The Boston Examiner en PressRelease 2026-04-22T11:00:00+00:00 Ocular Therapeutix™ to Host Investor Day on June 17, 2026 https://ml.globenewswire.com/media/20ee0f50-7288-4f81-8546-f2ad2050ddbf/small/ocul-logo-jpg.jpg https://thebostonexaminer.com/article/907153982-ekaru-awarded-gtia-cybersecurity-trustmark-for-excellence-in-cybersecurity-practices The Boston Examiner en PressRelease 2026-04-21T18:11:37+00:00 Ekaru Awarded GTIA Cybersecurity Trustmark for Excellence in Cybersecurity Practices https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24837480-gtia-cybersecurity-trustmark-as-1080x1080.png https://thebostonexaminer.com/article/907282132-syngenta-deploys-tetra-os-to-accelerate-scientific-discovery-through-industrial-scale-data-automation The Boston Examiner en PressRelease 2026-04-22T06:00:00+00:00 Syngenta Deploys Tetra OS to Accelerate Scientific Discovery Through Industrial-Scale Data Automation https://ml.globenewswire.com/media/MWUzYTA0NzgtOTgwMS00ZmYzLTgzYjEtMTFjZmQwNTMzMTY4LTEzMjA1NDMtMjAyNi0wNC0yMi1lbg==/tiny/TetraScience-Inc-.png https://thebostonexaminer.com/article/906796138-aptia-earns-gold-in-the-2026-hermes-creative-awards-for-event-marketing-campaign-at-hr-tech The Boston Examiner en PressRelease 2026-04-21T14:00:00+00:00 Aptia Earns Gold in the 2026 Hermes Creative Awards for Event Marketing Campaign at HR Tech https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/23790683-aptia-logo-223x226.png https://thebostonexaminer.com/article/906817046-uplizd-inc-launches-unified-infrastructure-for-enterprise-grade-agentic-ai The Boston Examiner en PressRelease 2026-04-21T14:00:00+00:00 Uplizd, Inc. Launches Unified Infrastructure for Enterprise-Grade Agentic AI https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24835855-uplizd-unified-infrastructure-880x1211.jpeg https://thebostonexaminer.com/article/906937548-the-new-england-center-for-children-celebrates-susan-langer-as-boston-red-sox-most-valuable-educator-honoree The Boston Examiner en PressRelease 2026-04-21T13:15:00+00:00 The New England Center for Children Celebrates Susan Langer as Boston Red Sox ‘Most Valuable Educator’ Honoree https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24836207-langer-with-wally-at-red-sox-4032x3024.jpeg https://thebostonexaminer.com/article/905898579-bookbud-ai-relaunches-with-enhanced-ai-book-creation-and-integrated-global-distribution The Boston Examiner en PressRelease 2026-04-21T13:00:00+00:00 BookBud.ai Relaunches with Enhanced AI Book Creation and Integrated Global Distribution https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24833426-bookbud-ai-hp-1-202604151356-2400x1350.png https://thebostonexaminer.com/article/906095998-authorvoices-ai-relaunches-with-ai-mastering-engine-that-delivers-pro-quality-audiobooks-in-under-an-hour The Boston Examiner en PressRelease 2026-04-21T13:00:00+00:00 AuthorVoices.ai Relaunches with AI Mastering Engine That Delivers Pro Quality Audiobooks in Under an Hour https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24834259-authorvoices-ai-hp-2-2026041612-2400x1350.png https://thebostonexaminer.com/article/906101620-selfpublishing-pro-relaunches-with-ai-powered-tools-for-authors-to-create-publish-and-market-books The Boston Examiner en PressRelease 2026-04-21T13:00:00+00:00 SelfPublishing.pro Relaunches with AI-Powered Tools for Authors to Create, Publish, and Market Books https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24834307-selfpublishing-pro-hp-3-2026041-2400x1350.png https://thebostonexaminer.com/article/906111128-ai-book-editing-surpasses-most-professional-editors-new-service-demonstrates-breakthrough The Boston Examiner en PressRelease 2026-04-21T13:00:00+00:00 AI Book Editing Surpasses Most Professional Editors, New Service Demonstrates Breakthrough https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24834372-bookeditor-io-hp-4-202604161359-2400x1350.png https://thebostonexaminer.com/article/906136441-ai-powered-platform-generates-fully-custom-children-s-books-from-uploaded-photos-in-minutes The Boston Examiner en PressRelease 2026-04-21T13:00:00+00:00 AI-Powered Platform Generates Fully Custom Children's Books From Uploaded Photos in Minutes https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24834522-starringmykid-com-hp-5-20260416-2400x1350.png https://thebostonexaminer.com/article/906319258-ai-book-trailer-platform-cuts-production-time-from-weeks-to-minutes-at-fraction-of-traditional-cost The Boston Examiner en PressRelease 2026-04-21T13:00:00+00:00 AI Book Trailer Platform Cuts Production Time from Weeks to Minutes at Fraction of Traditional Cost https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24835269-bookreelz-com-hp-6-202604171540-2400x1350.png https://thebostonexaminer.com/article/906507117-walkpunch-launches-ai-powered-punch-list-tool-that-converts-job-site-videos-into-trade-sorted-action-items The Boston Examiner en PressRelease 2026-04-21T13:00:00+00:00 WalkPunch Launches AI-Powered Punch List Tool That Converts Job-Site Videos Into Trade-Sorted Action Items https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24835614-walkpunch-com-hp-7-202604181211-2400x1350.png https://thebostonexaminer.com/article/901556457-sba-financed-internal-ownership-transitions-gain-momentum-among-engineering-firms-nationwide The Boston Examiner en PressRelease 2026-04-21T12:00:00+00:00 SBA-Financed Internal Ownership Transitions Gain Momentum Among Engineering Firms Nationwide https://thebostonexaminer.com/article/907010128-national-shattering-silence-coalition-calls-for-urgent-reform-after-preventable-psychiatric-system-failure-in-alabama The Boston Examiner en PressRelease 2026-04-21T12:00:00+00:00 National Shattering Silence Coalition Calls for Urgent Reform After Preventable Psychiatric System Failure in Alabama https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24836807-river-hammett-656x336.png https://thebostonexaminer.com/article/907230798-curiox-biosystems-signs-master-software-license-agreement-for-enterprise-scale-pluto-code-deployment The Boston Examiner en PressRelease 2026-04-22T00:00:00+00:00 Curiox Biosystems Signs Master Software License Agreement for Enterprise-Scale Pluto Code Deployment https://ml.globenewswire.com/media/2faf597f-471d-45ee-a32f-fdf0ed764592/small/curiox-png.png https://thebostonexaminer.com/article/907120116-tropigas-modernizes-mission-critical-energy-operations-with-creatio The Boston Examiner en PressRelease 2026-04-21T11:34:41+00:00 Tropigas Modernizes Mission-Critical Energy Operations with Creatio https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24837164-tropigas-1200x628.png https://thebostonexaminer.com/article/907207199-liberty-defense-announces-pricing-of-its-u-s-initial-public-offering The Boston Examiner en PressRelease 2026-04-21T21:18:47+00:00 Liberty Defense Announces Pricing of its U.S. Initial Public Offering https://ml.globenewswire.com/media/e3680d7e-614f-4715-8d2b-337dbd073cbc/small/liberty-logo-png.png https://thebostonexaminer.com/article/907207103-aktis-oncology-announces-presentation-of-first-clinical-imaging-and-dosimetry-data-for-aky-2519-at-the-2026-american-society-of-clinical-oncology The Boston Examiner en PressRelease 2026-04-21T21:00:00+00:00 Aktis Oncology Announces Presentation of First Clinical Imaging and Dosimetry Data for AKY-2519 at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting https://ml.globenewswire.com/media/490bbb9a-2b27-4a72-8d7a-333387326d8b/small/aktis-rgb-png.png https://thebostonexaminer.com/article/907195728-rgenta-therapeutics-announces-rgt-61159-clinical-poster-presentation-at-the-upcoming-2026-american-society-of-clinical-oncology-asco-annual-meeting The Boston Examiner en PressRelease 2026-04-21T20:30:00+00:00 Rgenta Therapeutics Announces RGT-61159 Clinical Poster Presentation at the Upcoming 2026 American Society of Clinical Oncology (ASCO) Annual Meeting https://ml.globenewswire.com/media/de2f6450-22c4-4c16-b785-04cea917de03/small/rgenta-logo-fullcolor-print-1-png.png https://thebostonexaminer.com/article/907197468-aspen-aerogels-provides-east-providence-facility-update The Boston Examiner en PressRelease 2026-04-21T20:30:00+00:00 Aspen Aerogels Provides East Providence Facility Update https://ml.globenewswire.com/media/d9832b9e-3339-4760-9351-f988900fc3b9/small/aspn-logo-jpg.jpg https://thebostonexaminer.com/article/907198302-rapport-therapeutics-presents-rap-219-focal-onset-seizure-phase-2a-follow-up-period-results-demonstrating-sustained-seizure-reduction-at-the-2026 The Boston Examiner en PressRelease 2026-04-21T20:30:00+00:00 Rapport Therapeutics Presents RAP-219 Focal Onset Seizure Phase 2a Follow-up Period Results Demonstrating Sustained Seizure Reduction at the 2026 American Academy of Neurology Annual Meeting https://ml.globenewswire.com/media/7777ee9b-f88b-4a59-a668-d81520f9d32c/small/rapport-logo-color-rgb-png.png https://thebostonexaminer.com/article/907195040-foghorn-therapeutics-presents-new-preclinical-data-for-selective-smarca2-inhibitor-fhd-909-and-for-selective-cbp-ep300-and-arid1b-degrader-programs The Boston Examiner en PressRelease 2026-04-21T20:05:00+00:00 Foghorn Therapeutics Presents New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and for Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting https://ml.globenewswire.com/media/742c7e36-c026-4cb2-b89a-933512e66fea/small/foghorn-logo-color-jpg.jpg https://thebostonexaminer.com/article/907195631-immuneering-to-present-new-survival-data-from-first-line-pancreatic-cancer-patients-treated-with-atebimetinib-mgnp-in-an-oral-presentation-at-the The Boston Examiner en PressRelease 2026-04-21T20:05:00+00:00 Immuneering to Present New Survival Data from First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP in an Oral Presentation at the 2026 ASCO Annual Meeting https://ml.globenewswire.com/media/81d0c83f-ae53-4d6e-9c5e-d6963e02f29d/small/immuneering-logo-cropped-1-jpg.jpg https://thebostonexaminer.com/article/907194936-beta-bionics-announces-first-quarter-2026-financial-results-and-raises-full-year-2026-guidance The Boston Examiner en PressRelease 2026-04-21T20:03:00+00:00 Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance https://ml.globenewswire.com/media/88df4d95-789c-467a-8481-f67e19e1adfa/small/beta-bionics-logo-2color-1200-png.png https://thebostonexaminer.com/article/907195777-wave-life-sciences-announces-hearing-on-proposed-redomiciliation-to-the-united-states The Boston Examiner en PressRelease 2026-04-21T20:01:00+00:00 Wave Life Sciences Announces Hearing on Proposed Redomiciliation to the United States https://ml.globenewswire.com/media/b2c5e218-8ae8-4dc2-b6f2-cf55b6b3b6e0/small/wave-life-sciences-logo-jpg.jpg https://thebostonexaminer.com/article/907183356-precede-biosciences-launches-precede-bio-insight-a-genome-wide-liquid-biopsy-for-functional-tumor-biology-at-aacr-2026 The Boston Examiner en PressRelease 2026-04-21T18:30:00+00:00 Precede Biosciences Launches Precede Bio Insight™, a Genome-Wide Liquid Biopsy for Functional Tumor Biology at AACR 2026 https://ml.globenewswire.com/media/adc7102a-f715-445b-9532-23260281465e/small/logo-png.png https://thebostonexaminer.com/article/907173076-ai-enhanced-medical-ventilators-drive-healthcare-digitization-as-investment-in-respiratory-care-technology-surges The Boston Examiner en PressRelease 2026-04-21T17:43:52+00:00 AI-Enhanced Medical Ventilators Drive Healthcare Digitization as Investment in Respiratory Care Technology Surges https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://thebostonexaminer.com/article/907163801-anaqua-establece-un-nuevo-est-ndar-de-protecci-n-de-marca-moderna-con-soluciones-impulsadas-por-ia The Boston Examiner en PressRelease 2026-04-21T16:40:13+00:00 Anaqua establece un nuevo estándar de protección de marca moderna con soluciones impulsadas por IA https://ml.globenewswire.com/media/93bf2cd3-dfb8-4753-8719-3d389eed2845/small/logo-anaqua-color-png.png https://thebostonexaminer.com/article/907163814 The Boston Examiner en PressRelease 2026-04-21T16:40:13+00:00 אנאקווה קובעת סטנדרט חדש להגנה מודרנית על מותגים עם פתרונות מבוססי בינה מלאכותית https://ml.globenewswire.com/media/93bf2cd3-dfb8-4753-8719-3d389eed2845/small/logo-anaqua-color-png.png https://thebostonexaminer.com/article/907163817-ai The Boston Examiner en PressRelease 2026-04-21T16:40:13+00:00 アナクア、AI駆動型ソリューションで、現代のブランド保護の新基準を打ち立てる https://ml.globenewswire.com/media/93bf2cd3-dfb8-4753-8719-3d389eed2845/small/logo-anaqua-color-png.png https://thebostonexaminer.com/article/907163843-anaqua-setzt-mit-ki-gest-tzten-l-sungen-neue-ma-st-be-f-r-modernen-markenschutz The Boston Examiner en PressRelease 2026-04-21T16:40:13+00:00 Anaqua setzt mit KI-gestützten Lösungen neue Maßstäbe für modernen Markenschutz https://ml.globenewswire.com/media/93bf2cd3-dfb8-4753-8719-3d389eed2845/small/logo-anaqua-color-png.png https://thebostonexaminer.com/article/907163857-anaqua-menetapkan-standard-baharu-bagi-perlindungan-jenama-moden-melalui-penyelesaian-dipacu-ai The Boston Examiner en PressRelease 2026-04-21T16:40:13+00:00 Anaqua Menetapkan Standard Baharu bagi Perlindungan Jenama Moden melalui Penyelesaian Dipacu AI https://ml.globenewswire.com/media/93bf2cd3-dfb8-4753-8719-3d389eed2845/small/logo-anaqua-color-png.png https://thebostonexaminer.com/article/907163867-anaqua-tablit-une-nouvelle-norme-en-mati-re-de-protection-moderne-des-marques-gr-ce-des-solutions-optimis-es-par-l-ia The Boston Examiner en PressRelease 2026-04-21T16:40:13+00:00 Anaqua établit une nouvelle norme en matière de protection moderne des marques grâce à des solutions optimisées par l’IA https://ml.globenewswire.com/media/93bf2cd3-dfb8-4753-8719-3d389eed2845/small/logo-anaqua-color-png.png https://thebostonexaminer.com/article/907163881-anaqua-ai The Boston Examiner en PressRelease 2026-04-21T16:40:13+00:00 Anaqua 以 AI 驱动型解决方案树立现代品牌保护新标杆 https://ml.globenewswire.com/media/93bf2cd3-dfb8-4753-8719-3d389eed2845/small/logo-anaqua-color-png.png https://thebostonexaminer.com/article/907163887-anaqua The Boston Examiner en PressRelease 2026-04-21T16:40:13+00:00 Anaqua 運用人工智能驅動的解決方案，為現代品牌保護訂立新標準 https://ml.globenewswire.com/media/93bf2cd3-dfb8-4753-8719-3d389eed2845/small/logo-anaqua-color-png.png https://thebostonexaminer.com/article/907163922-anaqua-ai The Boston Examiner en PressRelease 2026-04-21T16:40:13+00:00 Anaqua, AI 기반 솔루션으로 현대적 브랜드 보호의 새로운 기준 제시 https://ml.globenewswire.com/media/93bf2cd3-dfb8-4753-8719-3d389eed2845/small/logo-anaqua-color-png.png https://thebostonexaminer.com/article/907163951-anaqua-cria-novo-padr-o-de-prote-o-moderna-de-marca-com-solu-es-orientadas-por-ia The Boston Examiner en PressRelease 2026-04-21T16:40:13+00:00 Anaqua Cria Novo Padrão de Proteção Moderna de Marca com Soluções Orientadas por IA https://ml.globenewswire.com/media/93bf2cd3-dfb8-4753-8719-3d389eed2845/small/logo-anaqua-color-png.png https://thebostonexaminer.com/article/907153772-northeast-bank-announces-dates-for-fiscal-2026-third-quarter-earnings-results-and-conference-call The Boston Examiner en PressRelease 2026-04-21T15:00:00+00:00 Northeast Bank Announces Dates for Fiscal 2026 Third Quarter Earnings Results and Conference Call https://ml.globenewswire.com/media/ec44d25b-c247-4d5d-9264-10fb03e30aa8/small/nebank-cmyk-transparent-sm-png.png https://thebostonexaminer.com/article/907050852-stark-moving-and-storage-strengthens-boston-presence-with-new-downtown-location-and-enhanced-local-moving-fleet The Boston Examiner en PressRelease 2026-04-21T02:58:10+00:00 Stark Moving and Storage Strengthens Boston Presence with New Downtown Location and Enhanced Local Moving Fleet https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24466072-stark-movers-boston-220x78.png https://thebostonexaminer.com/article/907153754-black-diamond-therapeutics-announces-oral-presentation-of-silevertinib-phase-2-data-in-frontline-egfrm-nsclc-patients-at-the-2026-asco-annual-meeting The Boston Examiner en PressRelease 2026-04-21T14:40:00+00:00 Black Diamond Therapeutics Announces Oral Presentation of Silevertinib Phase 2 Data in Frontline EGFRm NSCLC Patients at the 2026 ASCO Annual Meeting https://ml.globenewswire.com/media/b8da4d92-789b-4f0a-a1e2-2739af370155/small/bdtxlogo-pantone3135c-png-png.png https://thebostonexaminer.com/article/907145614-dochub-expands-pdf-editing-capabilities-with-the-new-edit-text-feature The Boston Examiner en PressRelease 2026-04-21T14:17:23+00:00 DocHub Expands PDF Editing Capabilities With The New Edit Text Feature https://ml.globenewswire.com/media/73b52407-7228-4461-898e-10315d33abb0/medium/new-way-of-editing-in-dochub.png https://thebostonexaminer.com/article/907144137-dewpoint-therapeutics-reports-preclinical-data-on-oral-myc-condensate-modulator-at-aacr-2026 The Boston Examiner en PressRelease 2026-04-21T14:00:00+00:00 Dewpoint Therapeutics Reports Preclinical Data on Oral MYC Condensate Modulator at AACR 2026 https://ml.globenewswire.com/media/e6f24195-bede-49a6-a925-b7dceea78e57/small/dewpoint-logo-centered-full-color-png.png https://thebostonexaminer.com/article/907144160-disc-medicine-announces-oral-presentation-of-data-from-rally-mf-phase-2-trial-of-disc-0974-in-patients-with-myelofibrosis-and-anemia-at-the-american The Boston Examiner en PressRelease 2026-04-21T14:00:00+00:00 Disc Medicine Announces Oral Presentation of Data from RALLY-MF Phase 2 Trial of DISC-0974 in Patients with Myelofibrosis and Anemia at the American Society of Clinical Oncology (ASCO) Annual Meeting https://ml.globenewswire.com/media/d212c899-9a87-4500-9382-573dfe9f12af/small/disc-logo-horiz-fullcolor-rgb-jpg.jpg https://thebostonexaminer.com/article/907145037-progress-software-releases-2025-corporate-social-responsibility-report-underscoring-global-commitment-to-giving-back The Boston Examiner en PressRelease 2026-04-21T14:00:00+00:00 Progress Software Releases 2025 Corporate Social Responsibility Report, Underscoring Global Commitment to Giving Back https://ml.globenewswire.com/media/2a4a917f-af24-458f-b64e-25e5e5cc6c26/small/progress-logo-jpg.jpg https://thebostonexaminer.com/article/907137574-bevi-moves-beyond-water-unveils-brand-refresh-and-fully-connected-beverage-platform The Boston Examiner en PressRelease 2026-04-21T13:05:00+00:00 Bevi Moves Beyond Water, Unveils Brand Refresh and Fully Connected Beverage Platform https://ml.globenewswire.com/media/7a0e868f-a0f4-425a-9ffd-2bd134bc8492/medium/bevi-announced-a-brand-refresh-new-products-that-diversify-b.jpg https://thebostonexaminer.com/article/907134963-cangrade-adds-llm-choice-to-jules-ai-copilot-guided-by-ethical-ai The Boston Examiner en PressRelease 2026-04-21T13:00:00+00:00 Cangrade Adds LLM Choice to Jules AI Copilot, Guided by Ethical AI https://ml.globenewswire.com/media/e3bc045a-7a1f-466b-a408-e3ccd5ab2417/small/cangrade-logo-png.png https://thebostonexaminer.com/article/907135215-anaqua-sets-a-new-standard-for-modern-brand-protection-with-ai-driven-solutions The Boston Examiner en PressRelease 2026-04-21T13:00:00+00:00 Anaqua Sets a New Standard for Modern Brand Protection with AI-driven Solutions https://ml.globenewswire.com/media/93bf2cd3-dfb8-4753-8719-3d389eed2845/small/logo-anaqua-color-png.png https://thebostonexaminer.com/article/907135833-akari-therapeutics-asco-abstract-acceptance-highlights-potential-for-aktx-101-adc-to-treat-kras-mutant-tumors The Boston Examiner en PressRelease 2026-04-21T13:00:00+00:00 Akari Therapeutics ASCO Abstract Acceptance Highlights Potential for AKTX-101 ADC to Treat KRAS Mutant Tumors https://ml.globenewswire.com/media/8d978f50-07a9-40a3-be69-45f51ccd94d9/small/akari-logo-1-jpg.jpg https://thebostonexaminer.com/article/907126578-ipg-photonics-to-announce-first-quarter-2026-financial-results-on-may-5 The Boston Examiner en PressRelease 2026-04-21T12:00:00+00:00 IPG Photonics to Announce First Quarter 2026 Financial Results on May 5 https://ml.globenewswire.com/media/5825fb28-2af6-4779-82e4-989ded56e0a6/small/ipg-logo-jpg.JPG https://thebostonexaminer.com/article/907127048-cogent-biosciences-announces-oral-presentation-of-positive-phase-3-peak-trial-in-gastrointestinal-stromal-tumors-gist-at-the-2026-american-society The Boston Examiner en PressRelease 2026-04-21T12:00:00+00:00 Cogent Biosciences Announces Oral Presentation of Positive Phase 3 PEAK Trial in Gastrointestinal Stromal Tumors (GIST) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting https://ml.globenewswire.com/media/2b8cbfab-a4de-4e17-bdd6-7ef597a95d2e/small/cogent-biosciences-logo-rgb-png.png https://thebostonexaminer.com/article/907128506-milliporesigma-launches-first-bio-based-solvent-portfolio-for-high-performance-liquid-chromatography The Boston Examiner en PressRelease 2026-04-21T12:00:00+00:00 MilliporeSigma Launches First Bio-Based Solvent Portfolio for High-Performance Liquid Chromatography https://ml.globenewswire.com/media/Zjk3YzE3YjAtNjM2MC00MTc5LWJlM2MtMWQ5YjZhNWNhYWViLTUwMDE1NzEwMy0yMDI2LTA0LTIxLWVu/tiny/MilliporeSigma.png https://thebostonexaminer.com/article/907127966-bpgbio-appoints-former-oxford-pro-vice-chancellor-for-innovation-chas-bountra-ph-d-as-executive-vice-president-and-chief-scientific-officer The Boston Examiner en PressRelease 2026-04-21T11:05:00+00:00 BPGbio Appoints Former Oxford Pro-Vice Chancellor for Innovation Chas Bountra, Ph.D., as Executive Vice President and Chief Scientific Officer https://ml.globenewswire.com/media/4a0c4e8a-8478-4161-9bc1-cfcdc41c9462/medium/bpgbio-appoints-chas-bountra-ph-d-as-executive-vice-presiden.png https://thebostonexaminer.com/article/907126696-standard-biotools-to-announce-first-quarter-2026-financial-results-on-may-5-2026 The Boston Examiner en PressRelease 2026-04-21T11:00:00+00:00 Standard BioTools to Announce First Quarter 2026 Financial Results on May 5, 2026 https://ml.globenewswire.com/media/122934c3-b763-4386-89d1-3047d0704c17/small/sbt-new-august-2022-logo.png https://thebostonexaminer.com/article/907126754-vicor-corporation-reports-results-for-the-first-quarter-ended-march-31-2026 The Boston Examiner en PressRelease 2026-04-21T11:00:00+00:00 Vicor Corporation Reports Results for the First Quarter Ended March 31, 2026 https://ml.globenewswire.com/media/55117480-366f-4254-a0c3-1c89d863eb54/small/1200x628-4x-png.png https://thebostonexaminer.com/article/907127978-kala-bio-celebrates-trump-executive-order-as-game-changer-for-psychedelic-medicine The Boston Examiner en PressRelease 2026-04-21T11:00:00+00:00 Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine https://ml.globenewswire.com/media/15db4366-93ba-40fa-b80d-58cbdde3496e/small/kala-bio-logo-jpg.jpg https://thebostonexaminer.com/article/907128135-aavantgarde-announces-completion-of-recruitment-in-stella-natural-history-study The Boston Examiner en PressRelease 2026-04-21T11:00:00+00:00 AAVantgarde announces completion of recruitment in STELLA natural history study https://ml.globenewswire.com/media/e7ffd915-8158-436d-b9fe-8db1cb3597ce/small/logo-png.png https://thebostonexaminer.com/article/907117621-hyalex-orthopaedics-announces-fda-510-k-clearance-of-the-hyalex-slalom-mtp-hemiarthroplasty-system The Boston Examiner en PressRelease 2026-04-21T10:00:00+00:00 Hyalex Orthopaedics Announces FDA 510(k) Clearance of the HYALEX Slalom™ MTP Hemiarthroplasty System https://ml.globenewswire.com/media/2c148840-120a-41be-af54-0ad73f8a4f6b/small/hyalex-logo-vector-recreated-white-border-png.png https://thebostonexaminer.com/article/907002440-mayhew-tools-launches-new-3-pc-long-non-turning-pneumatic-set The Boston Examiner en PressRelease 2026-04-20T21:03:19+00:00 Mayhew Tools Launches New 3 Pc. Long Non-Turning Pneumatic Set https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/22821933-mayhew-tools-2000x1260.png https://thebostonexaminer.com/article/906282724-heygears-unveils-one-stop-3d-printing-solutions-for-elastomer-transparent-engineering-applications-at-rapid-tct-2026 The Boston Examiner en PressRelease 2026-04-20T16:00:00+00:00 HeyGears Unveils One-Stop 3D Printing Solutions for Elastomer, Transparent & Engineering Applications at RAPID+TCT 2026 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24835056-heygears-elastomer-3d-printing-1280x959.png https://thebostonexaminer.com/article/907008228-aktualisierung-bvi-gibt-bekannt-dass-virtuoso-eine-neue-chirurgische-plattform-mit-doppelfunktion-die-ce-kennzeichnung-gem-eu-mdr-erhalten The Boston Examiner en PressRelease 2026-04-20T21:28:54+00:00 AKTUALISIERUNG -- BVI gibt bekannt, dass Virtuoso®, eine neue chirurgische Plattform mit Doppelfunktion, die CE-Kennzeichnung gemäß EU-MDR erhalten hat https://ml.globenewswire.com/media/NjNkNTUyMTQtMGZiYS00MTczLTkxNDYtN2IxMmI2YTU0ZmMyLTEyNjQwMzItMjAyNi0wNC0yMC1kZQ==/tiny/BVI-Medical-Inc-.png https://thebostonexaminer.com/article/907008243-mise-jour-bvi-annonce-l-obtention-du-marquage-ce-au-titre-du-r-glement-europ-en-sur-les-dispositifs-m-dicaux-pour-virtuoso-une-toute-nouvelle The Boston Examiner en PressRelease 2026-04-20T21:28:54+00:00 MISE À JOUR -- BVI annonce l’obtention du marquage CE au titre du Règlement européen sur les dispositifs médicaux pour Virtuoso®, une toute nouvelle plateforme chirurgicale à double fonction https://ml.globenewswire.com/media/NjNkNTUyMTQtMGZiYS00MTczLTkxNDYtN2IxMmI2YTU0ZmMyLTEyNjQwMzItMjAyNi0wNC0yMC1mcg==/tiny/BVI-Medical-Inc-.png https://thebostonexaminer.com/article/907000429-cargurus-to-report-first-quarter-2026-financial-results The Boston Examiner en PressRelease 2026-04-20T20:05:00+00:00 CarGurus To Report First Quarter 2026 Financial Results https://ml.globenewswire.com/media/5e9ed825-143d-405a-9794-acd1a1ded2cc/small/cg-logo-2025-small-png.png https://thebostonexaminer.com/article/907000699-amwell-to-report-first-quarter-2026-operating-results The Boston Examiner en PressRelease 2026-04-20T20:05:00+00:00 Amwell® to report first quarter 2026 operating results https://ml.globenewswire.com/media/ff1989f5-0a6a-4e00-99dc-cb29a818aca5/small/amwell-logo-blue-2023-v02-rgb-2-png.png https://thebostonexaminer.com/article/907001167-kailera-announces-closing-of-initial-public-offering-and-full-exercise-of-underwriters-option-to-purchase-additional-shares The Boston Examiner en PressRelease 2026-04-20T20:05:00+00:00 Kailera Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares https://ml.globenewswire.com/media/c0b33a3d-0c2b-45b0-ace8-6ff585b41339/small/kailera-logo-png.png https://thebostonexaminer.com/article/907000519-flywire-to-announce-first-quarter-2026-earnings-on-may-5-2026 The Boston Examiner en PressRelease 2026-04-20T20:00:00+00:00 Flywire to Announce First Quarter 2026 Earnings on May 5, 2026 https://ml.globenewswire.com/media/9b1123f3-5f90-4036-ab7b-c4c3d1f5491b/small/flywire-logo-jpg.jpg https://thebostonexaminer.com/article/906982674-lung-cancer-therapeutics-market-to-reach-49-5-billion-by-2030-driven-by-rising-cancer-incidence-and-r-d-investment-surge The Boston Examiner en PressRelease 2026-04-20T18:19:26+00:00 Lung Cancer Therapeutics Market to Reach $49.5 Billion by 2030, Driven by Rising Cancer Incidence and R&D Investment Surge https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png